0001236031-19-000013.txt : 20190412 0001236031-19-000013.hdr.sgml : 20190412 20190412170005 ACCESSION NUMBER: 0001236031-19-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190411 FILED AS OF DATE: 20190412 DATE AS OF CHANGE: 20190412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAILLAVOINE BRUNO JEAN-MARIE CENTRAL INDEX KEY: 0001646989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 19746890 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-04-11 0 0000725363 CEL SCI CORP CVM 0001646989 BAILLAVOINE BRUNO JEAN-MARIE 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182 1 0 0 0 Options 5.65 2019-04-11 4 A 0 160000 0.01 A 2029-04-10 Common Stock 160000 277500 D The stock options vest in three (3) equal annual installments commencing one year after the grant date. Bruno Baillavoine 2019-04-12